StellaTUM: current consensus and discussion on pancreatic stellate cell research.
about
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective TreatmentKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsIrreversible electroporation and the pancreas: What we know and where we are going?Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challengesOncolytic viral therapy for pancreatic cancer: current research and future directionsPersistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinomaThe pancreas cancer microenvironmentSIBLINGs and SPARC families: their emerging roles in pancreatic cancerNitric oxide signals are interlinked with calcium signals in normal pancreatic stellate cells upon oxidative stress and inflammationSoluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxificationA bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines.Substrate Rigidity Controls Activation and Durotaxis in Pancreatic Stellate CellsEndogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo.Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells.The complex landscape of pancreatic cancer metabolismDesign, synthesis, and characterization of novel apigenin analogues that suppress pancreatic stellate cell proliferation in vitro and associated pancreatic fibrosis in vivo.Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluationComplex role for the immune system in initiation and progression of pancreatic cancer.Oncogenic KRAS signalling in pancreatic cancer.Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition.Risk factors for pancreatic cancer: underlying mechanisms and potential targets.Smarter drugs emerging in pancreatic cancer therapy.α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study.The P2X7 receptor supports both life and death in fibrogenic pancreatic stellate cellsHypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas.Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonistRhein, a natural anthraquinone derivative, attenuates the activation of pancreatic stellate cells and ameliorates pancreatic fibrosis in mice with experimental chronic pancreatitis.Imbalance of Wnt/Dkk negative feedback promotes persistent activation of pancreatic stellate cells in chronic pancreatitis.Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer.Exploiting base excision repair to improve therapeutic approaches for pancreatic cancerApigenin inhibits pancreatic stellate cell activity in pancreatitis.Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells.Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative studyPharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis.Retinoic Acid Ameliorates Pancreatic Fibrosis and Inhibits the Activation of Pancreatic Stellate Cells in Mice with Experimental Chronic Pancreatitis via Suppressing the Wnt/β-Catenin Signaling Pathway.The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma
P2860
Q26751520-FAC12916-DBBE-41CF-8E3C-16E57A4A6169Q26766065-ABE94284-6F43-4358-BCCE-85FC237E61BFQ26795522-69DEAE5A-4B39-420A-98D2-1AC75A98BED9Q26824034-852E5A17-6121-46AB-894E-32CC5B5F0A07Q27011439-858415A3-35A7-48FA-AE4A-C5AD15A320C2Q27012236-C4F1353C-5D41-426D-B8A1-08EA57601D58Q27026705-72F95323-23D0-496B-879F-D18AAD6E6B01Q27027759-36A507B2-6A0D-4CDA-96F5-4BE6EB2BD544Q27336032-6A457B57-AD58-4082-8708-00FDBB83BB50Q28822225-6AFFA7F6-E475-4E40-A973-072A67802180Q30557486-31AA77FB-D166-48B0-A875-FF3915001241Q30575256-8CACCDCE-856B-4347-BCD5-B3967B4BB26DQ30854135-07E356BC-0522-42D3-87DC-63D7845015F1Q33624331-1A8DB248-D1AC-4687-941D-D8CA4FFBBD45Q33668178-A644E4AD-4625-41A7-9700-EECED72DB2C8Q33801399-021BD544-F916-4833-942C-6984E3375278Q33827703-C4410E85-21B6-407F-A8EF-2CE6C270CC40Q33880435-4D664C5F-7333-4FC7-9DA0-A2FCA4A7165CQ33886981-632DA8F6-87E5-4F2F-8F21-B059C6404DC7Q34093784-89ED47D7-FDF2-468E-938D-8CF0CEB2D1D9Q34113460-AB0E73F8-547D-4A10-9A26-D10387A33BBAQ34336268-9568200F-97BD-4A02-B8A6-7581148E6815Q34400723-41989A9C-D823-4D05-8092-E1E45AE0C00BQ34410212-2F979227-6F21-4D84-BBAB-9F0B722CE1CAQ34499655-86714DC6-7A81-4AF9-BBC7-D80FFADA9604Q34531684-E64EE919-BCC5-4DAD-953F-0ED3E48E810DQ35010290-D4370485-603F-4CDB-B9E0-72ECFC00357CQ35043060-2949F5EE-BE44-4A40-B4C9-BD083377ED45Q35061485-0A730B79-55D4-4252-97E6-858AF39893E6Q35152912-11C9CA66-AA4D-4FE7-AF34-AED3AACEE230Q35161476-27DE7660-FC7B-4CAC-8F3D-94C0D16D564EQ35304445-83CE8DAD-58BB-4D46-A353-F0D8F367261EQ35596477-940707FF-1E70-42DE-AABA-46C2D0241A5EQ35602697-218E10E1-0D32-4805-B23D-27B34B55A94FQ35641422-B550AE57-3489-4492-B75B-645E50B9B0D0Q35679162-DAC3A6BC-BB7F-4E8D-B4A4-178CA378CD4FQ35695360-F9953AFB-3366-46D5-BC29-94981E21CC5EQ35695401-163974D1-B134-4D90-BE28-7C96E7CC37FBQ35837893-7B1C65C6-50C3-4A04-A690-8B9E31530F88Q35954277-198A52FB-A29B-4A3B-A1FF-3E36BAA359D5
P2860
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@ast
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@en
type
label
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@ast
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@en
prefLabel
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@ast
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@en
P2093
P2860
P50
P1433
P1476
StellaTUM: current consensus and discussion on pancreatic stellate cell research.
@en
P2093
Carolin Reiser-Erkan
Christoph W Michalski
Craig D Logsdon
Guido Adler
Hans-Joerg Habisch
Hidekazu Tsukamoto
Jörg Kleeff
Malte Buchholz
Massimo Pinzani
P2860
P304
P356
10.1136/GUTJNL-2011-301220
P407
P50
P577
2011-11-24T00:00:00Z
2012-02-01T00:00:00Z